富山大学附属病院呼吸器外科
富山大学附属病院呼吸器外科

学術実績

賞与・助成金

(代表のみ, 全30件)

  1. University of California Riverside Genomic Institute Grant (2003)
  2. University of California Riverside Discovery Grant (2004)
  3. 日本学術振興会科学研究費補助金 (基盤C) 「アディポネクチンの肺癌及び肺疾患に与える影響」No.20591674 (2008-2010)(代表)
  4. 日本学術振興会科学研究費補助金 (基盤C) 「ヒト脂肪由来幹細胞の障害肺、移植肺治療への実用化を目指す、肺生着、臓器保護の研究」　No.23592066 (2011-2013) (代表)
  5. 日本学術振興会科学研究費補助金 (萌芽)「脱細胞化、再細胞化技術を使った再生肺の脆弱性の改善と、臓器保護に関わる基礎研究」　No. 26670629 (2014-2017) (代表)
  6. 日本学術振興会科学研究費補助金 (基盤B)「異種-脱細胞化組織骨格の再細胞化による、再生気管、再生肺の移植研究」　No. 15H04944 (2015-2019) (代表)
  7. 日本学術振興会科学研究費補助金 (萌芽)「新規ex vivo肺癌研究モデルとしての小型ヒト再生肺の創出」　No. 17K19609 (2017-2020) (代表)
  8. 日本学術振興会科学研究費補助金 (基盤B) 「組織骨格を利用した再生臓器におけるハイブリッド型血管ニッチの確立と移植研究」　No. 19H03747 (2019-2023) (代表)
  9. 日本学術振興会科学研究費補助金 (国際共同研究強化B) 「Ex vivo再生肺創出への生理的刺激の最適化と国際基盤的研究ネットワークの構築」 No. 20KK0255 (2020-2024) (代表)
  10. 長崎大学 STAR創出プログラム (学内) 「Ex vivo 臓器再生を基盤とした疾患研究・薬剤評価プラットフォームの開発」(2021-2023) (代表)

国際学会

  • 2014年4月 “Making Frankenstein’s Lung in Japan. Invited speaker. Cincinnati Childrens’ Hospital, Cincinnati, U.S.A., April 10
  • 2014年11月 Decellularization and Recellularization Based Whole Lung Regeneration in Nagasaki University. 4th International Symposium of Asian Society for Aging Research, Beijing, Chiha, Oral presentation.
  • 2015年6月 A phase II study of concurrent chemoradiotherapy with cisplatin and oral S-1, followed by surgery for locally advanced non-small cell lung cancer. ASCO annual meeting 2015. .Cicago,USA, Jun 3-7 Poster discussion.
  • 2016年4月 Reverse translational research for identifying the correlation between EGFR mutation status and DPD protein expression in lung adenocarcinoma The American Association of Clinical Cancer Research (AACR) Annual Meeting New Orleans, Louisiana, U.S.A., April 16-20
  • 2018年5月 Potential of Adipose-Derived Stem/Stromal Cells for Lung Transplantation and Lung Tissue Engineering. Poster presesntation. American Thoracic Society (ATS) annual meeting 2018.San Diego, USA, May 18-23

論文業績

(一部抜粋, 全141件)

  1. Tsuchiya T, Matsumoto K, Miyazaki T, Doi R, Tomoshige K, Watanabe H, Kiya S, Miura T, Ishimaru H, Nagayasu T. Successful pulmonary artery stenting for occlusion at a constructed pericardial conduit after right upper double sleeve lobectomy. Gen Thorac Cardiovasc Surg. 2022 Apr;70(4):402-405.
  2. Tsuchiya T, Matsumoto K, Miyazaki T, Doi R, Tokunaga S, Yamaguchi H, Tomoshige K, Watanabe H, Nagayasu T, Sugio K. A randomized phase II study of S-1 monotherapy versus cisplatin with vinorelbine for completely resected stage II/IIIA non-small cell lung cancer: rationale and study protocol design for the LOGIK1702 study. BMC Cancer. 2021 Mar 8;21(1):249.
  3. Tsuchiya T, Kamohara R, Muraoka M, Nagayasu T, Saeki S, Takenoyama M, Suzuki M, Inada K, Tokunaga S, Hayashi T, Urabe S, Koga T, Akamine S, Sugio K. A single-arm, phase 2 study of adjuvant chemotherapy with oral tegafur-uracil for pathologically lymphovascular invasion positive stage IA non-small cell lung cancer: LOGIK0602 study. BMC Cancer. 2020 Dec 4;20(1):1192.
  4. Tsuchiya T, Doi R, Obata T, Hatachi G, Nagayasu T. Lung Microvascular Niche, Repair, and Engineering. Front Bioeng Biotechnol. 2020 Feb 21;8:105.
  5. Tsuchiya T, Matsumoto K, Miyazaki T, Yamaguchi H, Yamazaki T, Sano I, Fukuoka J, Nakamura Y, Yamasaki N, Nagayasu T. Concurrent chemoradiotherapy using cisplatin and S-1, followed by surgery for stage II/IIIA non-small cell lung cancer. Gen Thorac Cardiovasc Surg. 2019 Jun;67(6):537-543.
  6. Tsuchiya T, Mendez J, Calle EA, Hatachi G, Doi R, Zhao L, Suematsu T, Nagayasu T, Niklason LE. Ventilation-Based Decellularization System of the Lung. Biores Open Access. 2016 May 1;5(1):118-26.
  7. Tsuchiya T, Sivarapatna A, Rocco K, Nanashima A, Nagayasu T, and Niklason LE. Future prospects for tissue engineered lung transplantation Decellularization and recellularization-based whole lung regeneration. Organogenesis 2014 Jan 31;10(2):196-207.
  8. Tsuchiya T, Balestrini JL, Mendez JJ, Calle EA, Zhao L, Niklason LE. Influence of pH on Extracellular Matrix Preservation During Lung Decellularization. Tissue Eng Part C Methods. 2014 Dec;20(12):1028-36.
  9. Tsuchiya T, Arai J, Matsumoto K, Miyazaki T, Honda S, Tagawa T, Nakamura A, Taniguchi H, Sano I, Akamine S, Muraoka M, Hisano H, Yamasaki N, Nagayasu T. Prognostic Impact of the ABCC11/MRP8 Polymorphism in Adjuvant Oral Chemotherapy with S-1 for Non-Small Cell Lung Cancer. Chemotherapy. 2016;61(2):77-86.
  10. Tsuchiya T, Mendez J, Calle EA, Hatachi G, Doi R, Zhao L, Suematsu T, Nagayasu T, Niklason LE. Ventilation-Based Decellularization System of the Lung. Biores Open Access. 2016 May 1;5(1):118-26.
  11. Tsuchiya T, Nagayasu T, Yamasaki N, Matsumoto K, Miyazaki T, Tagawa T, Nakamura A, Minami H, Taniguchi H, Akamine S, Hisano H, Taniguchi Y. A multicenter phase II study of adjuvant chemotherapy with oral fluoropyrimidine S-1 for non-small-cell lung cancer: high completion and survival rates. Clin Lung Cancer. 2012 Nov;13(6):464-9.
  12. Tsuchiya T, Hashizume S, Akamine S, Muraoka M, Honda S, Tsuji K, Urabe S, Hayashi T, Yamasaki N, Nagayasu T. Upstaging by vessel invasion improves the pathology staging system of non-small cell lung cancer. Chest. 2007 Jul;132(1):170-7.
  13. Tsuchiya T, Akamine S, Muraoka M, Kamohara R, Tsuji K, Urabe S, Honda S, Yamasaki N. Stage IA non-small cell lung cancer: vessel invasion is a poor prognostic factor and a new target of adjuvant chemotherapy. Lung Cancer. 2007 Jun;56(3):341-8.
  14. Tsuchiya T, Higami Y, Komatsu T, Tanaka K, Honda S, Yamaza H, Chiba T, Ayabe H, Shimokawa I. Acute stress response in calorie-restricted rats to lipopolysaccharide-induced inflammation. Mech Ageing Dev. 2005 May;126(5):568-79.
  15. Tsuchiya T, Dhahbi JM, Cui X, Mote PL, Bartke A, Spindler SR.　Additive regulation of hepatic gene expression by dwarfism and caloric restriction. Physiol Genomics. 2004 May 19;17(3):307-15.